Developer docs
API playgroundTry for free, no card

Search company profiles

Indira IVF

Full company profile

uuid000598k

Namestring
Indira IVF
Legal namestring
Indira IVF Hospital Limited
Websiteurl
indiraivf.com
Company typeenum
Private
Founded yearint
1988
Descriptiontext

Indira IVF Hospital Limited, headquartered in Udaipur and founded in 1988, operates India's largest chain of specialty fertility clinics with 200+ centres spread across more than 20 states. The company delivers a comprehensive assisted reproductive technology (ART) portfolio spanning IVF, ICSI, IUI, laparoscopy, hysteroscopy, blastocyst culture and embryo transfer, laser-assisted hatching, cryopreservation, and donor programmes (ovum, embryo, sperm), alongside advanced diagnostics such as PGT-A, Micro TESE, and DNA Fragmentation Index testing. Supporting clinical operations are proprietary laboratory platforms including a Closed Working Chamber, Electronic Witness Technology, 24X7 monitoring, a Microfluidic Sperm Sorter, an IoT-based Labcare Monitoring and Alarming System (minute-level telemetry with deviation alerts), and an Air Monitoring System tracking TVOC, CO2, PM2.5, humidity, and temperature.

The company serves individual patients — primarily couples facing tubal-peritoneal, male factor, endometriosis, anovulation, or unexplained infertility, plus women seeking elective egg freezing. Revenue is generated on a pay-as-you-go per-cycle basis, with IVF treatments priced between Rs 1.2 lakh and Rs 2.5 lakh per cycle and zero-interest EMI options offered through third-party financiers. Go-to-market is sales-led via direct clinic presence rather than third-party distribution, supported by content marketing (blog, YouTube, fertility calculators, a personalized success-rate calculator) that drives organic top-of-funnel demand.

Indira IVF is a privately held company backed by Swedish private equity firm EQT (BPEA EQT), which invested $656 million in 2024. The company has received SEBI approval for a planned Rs 3,500 crore IPO via the confidential pre-filing route and is using the proceeds window to consolidate geographic gaps — exemplified by the April 2026 acquisition of Kolkata-based Abha Surgy Healthcare, the June 2026 Whitefield (Bengaluru) upgrade, and the June 2026 Hassan greenfield. Indira Fertility Academy functions as an in-house training and credentialing arm, supplying the clinical talent pipeline. The leadership team is a mix of founder-family directors (Ajay Murdia as Chairman, Kshitiz Murdia, Nitiz Murdia, Manish Khatri) and appointed CXOs covering operations, medical excellence, finance/legal, and international business.

Short descriptiontext

Indira IVF Hospital Limited is India's largest single-specialty fertility chain, operating 200+ centres across 20+ states and offering IVF, ICSI, IUI, advanced ART, and cryopreservation services to individual patients experiencing infertility. The company is EQT-backed, preparing a Rs 3,500 crore IPO.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersUdaipur, India
HQ citystring
Udaipur
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
IVF treatment services, fertility clinic services, assisted reproductive technology, infertility treatment, fertility preservation
Industry3 codes
PRIMARYHLAFAJAD
Fertility, Reproductive Endocrinology & IVF Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYHLAKAJAC
Reproductive Endocrinology & Infertility (IVF/Fertility)
SECONDARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
NAICS code1 code
  • Family Planning Centers62141
SIC code2 codes
  • Services-Specialty Outpatient Facilities, Nec8093
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Fertility Clinics
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Fertility Treatment Services
TypeProfessional Services
Description

Indira IVF generates revenue through providing comprehensive fertility treatments including IVF, ICSI, IUI, laparoscopy, hysteroscopy, blastocyst culture and embryo transfer, laser assisted hatching, and advanced treatments. Services include infertility testing, fertility preservation (cryopreservation), and donor programs.

indiraivf.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D
Pricing details1 tier
1IVF treatment cycles
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Costs ranging from Rs 1.2 lakh to Rs 2.5 lakh per cycle in India. Overall IVF success rate reported at 72%+ based on positive pregnancy blood tests from procedures at own and operated clinics during financial year ending March 2025.

businesstoday.in
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Indira IVF operates a chain of specialty fertility clinics delivering assisted reproductive technology (ART) services including IVF, ICSI, IUI, laparoscopy, hysteroscopy, blastocyst culture and embryo transfer, laser assisted hatching, fertility preservation (cryopreservation), donor programs (egg, embryo, sperm), advanced treatments (PGT-A, Micro TESE, DFI, PLI), and infertility diagnostics. Treatments are delivered through 200+ centers across more than 20 Indian states using standardized clinical protocols and advanced laboratory systems.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 72%+ overall IVF success rate based on positive pregnancy blood tests from IVF procedures at own and operated clinics in India during FY2025
+2 more records
Product overview1 text field

Indira IVF operates as a chain of specialty fertility clinics offering a comprehensive portfolio of assisted reproductive technology (ART) services. The core offerings include IVF (In Vitro Fertilization), ICSI (Intracytoplasmic Sperm Injection), IUI (Intrauterine Insemination), laparoscopy, and hysteroscopy procedures. Advanced treatments include Micro TESE, PGT-A (Preimplantation Genetic Testing), DNA Fragmentation Index testing, and cryopreservation services for eggs, sperm, and embryos. The company provides donor programs (ovum, embryo, and sperm donation) and diagnostic services including infertility workup, semen analysis, and sonography. Supporting the clinical services are technology platforms including Closed Working Chamber, Electronic Witness Technology, 24X7 Monitoring System, Microfluidic Sperm Sorter, Labcare Monitoring and Alarming System, and Air Monitoring System. Indira IVF also operates Indira Fertility Academy offering professional training courses. The company has expanded to over 200 centres across India, making it India's largest IVF chain.

Product and service9 records
1In Vitro Fertilization (IVF)
CategoryAssisted Reproductive Technology
Description

A fertility treatment where fertilization and embryo development happen outside the uterus followed by the Embryo Transfer Procedure; offered to couples unable to conceive naturally.

2Intracytoplasmic Sperm Injection (ICSI)
CategoryAssisted Reproductive Technology
Description

A variation of IVF where a single sperm is injected directly into the female egg for fertilization; targeted at male factor infertility cases.

3Intrauterine Insemination (IUI)
CategoryAssisted Reproductive Technology
Description

Procedure where top-quality sperm of a male partner are injected into the female's reproductive system to fertilize the eggs.

4Laparoscopy
CategorySurgical Fertility Treatment
Description

Diagnostic and treatment procedure effective for endometriosis, ovarian cystectomy, myomectomy, treating anatomical abnormalities, and lysis of uterine adhesions.

5Hysteroscopy
CategorySurgical Fertility Treatment
Description

Diagnostic and surgical procedure used to identify and treat causes of infertility such as fibroids, polyps, and other anatomical defects.

6Blastocyst Culture and Embryo Transfer
CategoryAssisted Reproductive Technology
Description

Part of IVF/ICSI where the embryo is cultured for 5–6 days before being transferred into the woman's uterus for implantation and pregnancy.

7Laser Assisted Hatching (LAH)
CategoryAssisted Reproductive Technology
Description

Clinical procedure that assists IVF treatment by creating an opening in the embryo's outer shell to increase chances of successful implantation.

8Cryopreservation
CategoryFertility Preservation
Description

Fertility preservation service covering oocyte (egg) freezing, sperm cryopreservation, and embryo cryopreservation for future frozen embryo transfer.

9Ovum Donor (Egg Donor) Program
CategoryDonor Program
Description

Third-party reproduction program using eggs from a donor when the female partner is unable to produce healthy eggs for fertilization.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeOthersAnnounced on2026-04-16
Description

Indira IVF acquired Kolkata-based Abha Surgy Healthcare Pvt Ltd as part of its expansion strategy in preparation for a planned Rs 3,500 crore IPO. This represents a strategic acquisition to strengthen presence in the Eastern India market.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Bloom Fertility Center
TypeDirect peer
Description

India-based fertility clinic chain offering IVF, IUI, ICSI, and male infertility treatments with multiple centers. Comparable as a directly competing specialty fertility chain with similar technology stack and pricing.

TypeDirect peer
Description

One of India's largest pure-play IVF chains with ~100 centers across the country. Directly comparable as a multi-center fertility chain offering IVF, ICSI, IUI, and advanced ART with similar patient demographic.

TypeDirect peer
Description

Multi-country IVF chain (UAE, India) offering comprehensive fertility services with strong technology emphasis. Comparable as an advanced-ART-focused chain competing for premium patients in Indian metros.

4Manipal Fertility
TypeBroad incumbent
Description

Fertility arm of Manipal Hospitals, a large hospital group. Comparable as a national fertility service provider operating within a broader hospital network rather than as a focused single-specialty chain.

TypeDirect peer
Description

Indian fertility and maternity hospital chain backed by private equity, offering IVF, IUI, and ICSI with a strong metro presence. Comparable as a PE-backed, multi-city specialty fertility provider competing for the same patient cohort.

TypeBroad incumbent
Description

Fertility arm of Apollo Hospitals, one of India's largest hospital chains. Comparable as a national fertility provider, but operates as part of a broader multi-specialty hospital portfolio rather than as a single-specialty focused chain.

TypeEmerging player
Description

Indian fertility chain focused on advanced reproductive technology with growing metro presence. Comparable as an emerging multi-center IVF player pursuing similar patient outcomes through standardized lab technology.

TypeDirect peer
Description

Single-specialty IVF chain operating across multiple Indian states with standardized protocols. Comparable as a regional-to-pan-India fertility chain targeting similar ART patients with comparable service menus.

TypeDirect peer
Description

European-headquartered fertility chain with significant India operations offering IVF, ICSI, and donor programs. Comparable as a multi-center fertility chain with standardized protocols and similar service breadth.

10Fortis La Femme (Fertility)
TypeBroad incumbent
Description

Women's health and fertility services under Fortis Healthcare, a major hospital chain. Comparable as a national fertility services provider operating within a multi-specialty hospital infrastructure.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Indira IVF

Fertility Clinicsindiraivf.com

Indira IVF Hospital Limited is India's largest single-specialty fertility chain, operating 200+ centres across 20+ states and offering IVF, ICSI, IUI, advanced ART, and cryopreservation services to individual patients experiencing infertility. The company is EQT-backed, preparing a Rs 3,500 crore IPO.

What Indira IVF does

Indira IVF Hospital Limited, headquartered in Udaipur and founded in 1988, operates India's largest chain of specialty fertility clinics with 200+ centres spread across more than 20 states. The company delivers a comprehensive assisted reproductive technology (ART) portfolio spanning IVF, ICSI, IUI, laparoscopy, hysteroscopy, blastocyst culture and embryo transfer, laser-assisted hatching, cryopreservation, and donor programmes (ovum, embryo, sperm), alongside advanced diagnostics such as PGT-A, Micro TESE, and DNA Fragmentation Index testing. Supporting clinical operations are proprietary laboratory platforms including a Closed Working Chamber, Electronic Witness Technology, 24X7 monitoring, a Microfluidic Sperm Sorter, an IoT-based Labcare Monitoring and Alarming System (minute-level telemetry with deviation alerts), and an Air Monitoring System tracking TVOC, CO2, PM2.5, humidity, and temperature.

The company serves individual patients — primarily couples facing tubal-peritoneal, male factor, endometriosis, anovulation, or unexplained infertility, plus women seeking elective egg freezing. Revenue is generated on a pay-as-you-go per-cycle basis, with IVF treatments priced between Rs 1.2 lakh and Rs 2.5 lakh per cycle and zero-interest EMI options offered through third-party financiers. Go-to-market is sales-led via direct clinic presence rather than third-party distribution, supported by content marketing (blog, YouTube, fertility calculators, a personalized success-rate calculator) that drives organic top-of-funnel demand.

Indira IVF is a privately held company backed by Swedish private equity firm EQT (BPEA EQT), which invested $656 million in 2024. The company has received SEBI approval for a planned Rs 3,500 crore IPO via the confidential pre-filing route and is using the proceeds window to consolidate geographic gaps — exemplified by the April 2026 acquisition of Kolkata-based Abha Surgy Healthcare, the June 2026 Whitefield (Bengaluru) upgrade, and the June 2026 Hassan greenfield. Indira Fertility Academy functions as an in-house training and credentialing arm, supplying the clinical talent pipeline. The leadership team is a mix of founder-family directors (Ajay Murdia as Chairman, Kshitiz Murdia, Nitiz Murdia, Manish Khatri) and appointed CXOs covering operations, medical excellence, finance/legal, and international business.

Indira IVF firmographics

Firmographics
Name
Indira IVF
Legal name
Indira IVF Hospital Limited
Website
https://indiraivf.com
Company type
Private
Founded year
1988
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Indira IVF Hospital Limited is India's largest single-specialty fertility chain, operating 200+ centres across 20+ states and offering IVF, ICSI, IUI, advanced ART, and cryopreservation services to individual patients experiencing infertility. The company is EQT-backed, preparing a Rs 3,500 crore IPO.
Ownership category
akta.pro rank

Indira IVF industry classification

Industry
Product category
Fertility Clinics
NAICS
Family Planning Centers (62141)
SIC
Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro industry
PRIMARYHLAFAJAD
Fertility, Reproductive Endocrinology & IVF Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYHLAKAJAC
Reproductive Endocrinology & Infertility (IVF/Fertility)
SECONDARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)

Keywords

  • IVF treatment services
  • Fertility clinic services
  • Assisted reproductive technology
  • Infertility treatment
  • Fertility preservation

Where Indira IVF is headquartered

Location

Headquarters

HQ city
Udaipur
HQ country
India
HQ region
Asia

Offices4 records

Markets served

Indira IVF business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

  1. Fertility Treatment Services: Indira IVF generates revenue through providing comprehensive fertility treatments including IVF, ICSI, IUI, laparoscopy, hysteroscopy, blastocyst culture and embryo transfer, laser assisted hatching, and advanced treatments. Services include infertility testing, fertility preservation (cryopreservation), and donor programs.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goIVF treatment cycles

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Indira IVF product offering

Product offering

Core offering

Indira IVF operates a chain of specialty fertility clinics delivering assisted reproductive technology (ART) services including IVF, ICSI, IUI, laparoscopy, hysteroscopy, blastocyst culture and embryo transfer, laser assisted hatching, fertility preservation (cryopreservation), donor programs (egg, embryo, sperm), advanced treatments (PGT-A, Micro TESE, DFI, PLI), and infertility diagnostics. Treatments are delivered through 200+ centers across more than 20 Indian states using standardized clinical protocols and advanced laboratory systems.

Product overview

Indira IVF operates as a chain of specialty fertility clinics offering a comprehensive portfolio of assisted reproductive technology (ART) services. The core offerings include IVF (In Vitro Fertilization), ICSI (Intracytoplasmic Sperm Injection), IUI (Intrauterine Insemination), laparoscopy, and hysteroscopy procedures. Advanced treatments include Micro TESE, PGT-A (Preimplantation Genetic Testing), DNA Fragmentation Index testing, and cryopreservation services for eggs, sperm, and embryos. The company provides donor programs (ovum, embryo, and sperm donation) and diagnostic services including infertility workup, semen analysis, and sonography. Supporting the clinical services are technology platforms including Closed Working Chamber, Electronic Witness Technology, 24X7 Monitoring System, Microfluidic Sperm Sorter, Labcare Monitoring and Alarming System, and Air Monitoring System. Indira IVF also operates Indira Fertility Academy offering professional training courses. The company has expanded to over 200 centres across India, making it India's largest IVF chain.

Differentiator

Problem solved

Functional benefit

Products and services

  • In Vitro Fertilization (IVF) A fertility treatment where fertilization and embryo development happen outside the uterus followed by the Embryo Transfer Procedure; offered to couples unable to conceive naturally.
  • Intracytoplasmic Sperm Injection (ICSI) A variation of IVF where a single sperm is injected directly into the female egg for fertilization; targeted at male factor infertility cases.
  • Intrauterine Insemination (IUI) Procedure where top-quality sperm of a male partner are injected into the female's reproductive system to fertilize the eggs.
  • Laparoscopy Diagnostic and treatment procedure effective for endometriosis, ovarian cystectomy, myomectomy, treating anatomical abnormalities, and lysis of uterine adhesions.
  • Hysteroscopy Diagnostic and surgical procedure used to identify and treat causes of infertility such as fibroids, polyps, and other anatomical defects.
  • Blastocyst Culture and Embryo Transfer Part of IVF/ICSI where the embryo is cultured for 5–6 days before being transferred into the woman's uterus for implantation and pregnancy.
  • Laser Assisted Hatching (LAH) Clinical procedure that assists IVF treatment by creating an opening in the embryo's outer shell to increase chances of successful implantation.
  • Cryopreservation Fertility preservation service covering oocyte (egg) freezing, sperm cryopreservation, and embryo cryopreservation for future frozen embryo transfer.
  • Ovum Donor (Egg Donor) Program Third-party reproduction program using eggs from a donor when the female partner is unable to produce healthy eggs for fertilization.

Quantifiable outcome

  • 72%+ overall IVF success rate based on positive pregnancy blood tests from IVF procedures at own and operated clinics in India during FY2025
  • +2 more outcomes

Companies that use Indira IVF

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Indira IVF technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature9 records

Indira IVF partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Abha Surgy Healthcare Pvt LtdminorOthers · 16 April 2026Indira IVF acquired Kolkata-based Abha Surgy Healthcare Pvt Ltd as part of its expansion strategy in preparation for a planned Rs 3,500 crore IPO. This represents a strategic acquisition to strengthen presence in the Eastern India market.

Scale indicators9 records

Recent moves9 records

Expansion highlights6 records

Indira IVF competitors and assessment

Company assessment

Direct peers

  • Bloom Fertility Center: India-based fertility clinic chain offering IVF, IUI, ICSI, and male infertility treatments with multiple centers. Comparable as a directly competing specialty fertility chain with similar technology stack and pricing.
  • Nova IVF Fertility: One of India's largest pure-play IVF chains with ~100 centers across the country. Directly comparable as a multi-center fertility chain offering IVF, ICSI, IUI, and advanced ART with similar patient demographic.
  • ART Fertility Clinics: Multi-country IVF chain (UAE, India) offering comprehensive fertility services with strong technology emphasis. Comparable as an advanced-ART-focused chain competing for premium patients in Indian metros.
  • Cloudnine Fertility: Indian fertility and maternity hospital chain backed by private equity, offering IVF, IUI, and ICSI with a strong metro presence. Comparable as a PE-backed, multi-city specialty fertility provider competing for the same patient cohort.
  • Oasis Fertility: Single-specialty IVF chain operating across multiple Indian states with standardized protocols. Comparable as a regional-to-pan-India fertility chain targeting similar ART patients with comparable service menus.
  • Medicover Fertility: European-headquartered fertility chain with significant India operations offering IVF, ICSI, and donor programs. Comparable as a multi-center fertility chain with standardized protocols and similar service breadth.

Broad incumbents

  • Manipal Fertility: Fertility arm of Manipal Hospitals, a large hospital group. Comparable as a national fertility service provider operating within a broader hospital network rather than as a focused single-specialty chain.
  • Apollo Fertility: Fertility arm of Apollo Hospitals, one of India's largest hospital chains. Comparable as a national fertility provider, but operates as part of a broader multi-specialty hospital portfolio rather than as a single-specialty focused chain.
  • Fortis La Femme (Fertility): Women's health and fertility services under Fortis Healthcare, a major hospital chain. Comparable as a national fertility services provider operating within a multi-specialty hospital infrastructure.

Emerging players

  • Motherhood Fertility & IVF: Indian fertility chain focused on advanced reproductive technology with growing metro presence. Comparable as an emerging multi-center IVF player pursuing similar patient outcomes through standardized lab technology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Indira IVF social profiles

Digital presence

Indira IVF financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Indira IVF leadership team

Management profile

Number of profiles

Profiles8 records

Indira IVF subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Indira IVF funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Indira IVF M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Indira IVF

What does Indira IVF do?

Indira IVF operates a chain of specialty fertility clinics delivering assisted reproductive technology (ART) services including IVF, ICSI, IUI, laparoscopy, hysteroscopy, blastocyst culture and embryo transfer, laser assisted hatching, fertility preservation (cryopreservation), donor programs (egg, embryo, sperm), advanced treatments (PGT-A, Micro TESE, DFI, PLI), and infertility diagnostics. Treatments are delivered through 200+ centers across more than 20 Indian states using standardized clinical protocols and advanced laboratory systems.

Is Indira IVF a public or private company?

Indira IVF is a private company. It is classified as private equity controlled and is currently operating.

When was Indira IVF founded?

Indira IVF was founded in 1988. It employs 1,001 to 5,000 people.

Where is Indira IVF based?

Indira IVF is headquartered in Udaipur, India, in the Asia region.

How does Indira IVF make money?

One revenue line is on record: fertility Treatment Services.

Who are Indira IVF's main competitors?

Direct peers on record are Bloom Fertility Center, Nova IVF Fertility, ART Fertility Clinics, Cloudnine Fertility, Oasis Fertility and Medicover Fertility. Broad incumbents are Manipal Fertility, Apollo Fertility and Fortis La Femme (Fertility). Motherhood Fertility & IVF is listed as an emerging player.

Does Indira IVF have an API?

No public API is recorded for Indira IVF.

What industry is Indira IVF in?

Indira IVF's product category is Fertility Clinics. Its primary akta.pro industry code is HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers, with a secondary code of HLAKAJAC, Reproductive Endocrinology & Infertility (IVF/Fertility). Its NAICS code is 62141 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business News TodayEQT is said to consider selling India’s biggest IVF chain Indira- Moneycontrol.comEQT AB is considering selling India's largest IVF chain, Indira IVF Hospital Ltd., with an adviser involved. The Swedish firm may seek a valuation of at least $1.5 billion, having acquired the company in 2023 and withdrawn its IPO prospectus.BloombergEQT Is Said to Consider Selling India’s Biggest IVF Chain IndiraEQT AB is considering selling India's largest IVF chain, Indira IVF Hospital Ltd., with an adviser involved. The Swedish firm may seek a valuation of at least $1.5 billion for the company.The KenIndira IVF has a competition problem. Kerala could be the answerIndira IVF, India's largest fertility chain, is acquiring a Kerala clinic, following Birla Fertility and Nova IVF's recent purchases. The state's low birth rate and high trust in doctors make it difficult for new chains to gain footfall. The article suggests Kerala could be the answer to Indira's competition problem.Digital Health NewsIndira IVF in Talks to Acquire Sabine Hospital in INR 1,300 Cr DealIndira IVF is in talks to acquire a 70-75% stake in Sabine Hospital, valuing the chain at ₹1,200-1,300 crore. Sabine, which performs over 6,000 IVF cycles annually, was acquired by CX Partners in 2024 at ₹835 crore. The deal comes ahead of Indira IVF's planned ₹3,500-crore IPO.WhalesbookIndira IVF Plans ₹1,300 Crore Buyout of Kerala’s Sabine HospitalIndira IVF is in advanced talks to acquire a 70-75% stake in Kerala's Sabine Hospital for up to Rs 1,300 crore, part of its expansion ahead of a planned IPO. The deal would provide an exit for investor CX Partners and intensify competition in the South Indian market.The Times of IndiaIndira IVF in talks to acquire Sabine in nearly Rs 1,300 crore dealIndira IVF is in talks to acquire a 70-75% stake in Sabine, a CX Partners-owned fertility chain, in a deal likely valued at Rs 1,200-1,300 crore. Sabine is expected to post revenue of Rs 230-250 crore and EBITDA of Rs 70-80 crore in FY27. Indira IVF, preparing for a Rs 3,500 crore IPO, has been on an acquisition spree.DealStreetAsiaAdvent to buy 25% in India's Yatharth Hospital for $328.5 millionAdvent International invested $328.5 million for a 24.9% stake in Yatharth Hospital, sending shares to a record high of 1,067 rupees. The deal adds to private equity activity in India's healthcare sector, with KKR and Blackstone also making major acquisitions. Yatharth plans to expand capacity to 3,250 beds.HrtodayYellow Fertility & IVF Elevates Varun Gandhi to Chief Business Officer – India and InternationalYellow Fertility & IVF Centre has promoted Varun Gandhi to Chief Business Officer – India and International, expanding his leadership responsibilities across the company's domestic and international operations. Gandhi brings nearly two decades of experience in healthcare sales and business development, previously holding senior roles at Indira IVF Group, Sanzyme, and Panacea Biotec. In this expanded role, he will leverage his background to support the organization's growth journey in India and overseas markets.Elets BFSIIndira IVF Appoints Vinesh Gadhia as CEO of M&A Platform to Drive Strategic ExpansionIndira IVF Group has appointed Vinesh Gadhia as CEO of its Mergers & Acquisitions Platform to drive inorganic growth and expand its national footprint in India's fertility care sector. Gadhia, who previously led Ferty9 Fertility Center and held positions at ART Fertility Clinics and Nova IVF Fertility, brings over three decades of healthcare leadership experience to the role. The appointment aligns with increasing consolidation and investor interest in India's rapidly growing fertility care industry.Elets BFSIIndira IVF Appoints Vinesh Gadhia as CEO of M&A Platform to Drive Strategic ExpansionIndira IVF Group appointed Vinesh Gadhia as CEO of its M&A platform to drive inorganic growth and expansion. Gadhia, with over three decades of experience in fertility care and healthcare services, will oversee acquisition planning and integration. The appointment aims to strengthen Indira IVF's position in India's fertility care sector amid rising demand and consolidation.